Browse short videos 
, PDFs, articles 
, podcast episodes, presentations, and webinars to connect with the Knowing Diabetes community. 
Why should you join our platform?
You will have access to everything in our media library. This includes short and longer videos, articles, PDFs, tools, webinars, events, and more. If you choose, you will be notified when there are new launches on the platform and where to sign up to participate in diabetes-related research.
Registering for the platform is quick, easy, and completely free. Once you're signed up, you'll have access to a wealth of comprehensive, evidence-based, and reliable information designed to support your journey in managing diabetes. Our resources are tailored to meet diverse needs, offering up-to-date content that you can trust, all in one convenient place.
Explore the Knowing Diabetes Study Finder
The Knowing Diabetes Study Finder is a user-friendly AI tool designed for people with diabetes, their family members, and caregivers. By answering a few questions, you can quickly find nearby diabetes research studies seeking participants. Researchers and program facilitators can also submit their studies, keeping the database current and ensuring participants have access to the latest opportunities in diabetes research.
Read the latest articles
Discover our blog archive
What to Expect When Starting Semaglutide or Tirzepatide?
Semaglutide and tirzepatide are 2 drugs that are frequently used to manage type 2 diabetes. Semaglutide is marketed as either Ozempic or Wegovy and tirzepatide is marketed as either Mounjaro or Zepbound. They are excellent glucose lowering drugs and may also lower blood pressure. They also typically lower weight, reduce appetite and food cravings, with...
Learn more
Will My Children Inherit My Diabetes?
Diabetes is very common. Although its frequency varies with ancestry, an average of one of every nine or ten Canadians has diabetes. More than 90% of these people have type 2 diabetes, while less than 10% have type 1 diabetes. There is no question that genetics plays a role in the development of both types...
Learn more
Off-Label Use of Drugs Like Semaglutide and Tirzepatide in People With Type 1 Diabetes
The drugs semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Mounjaro and Zepbound) are widely used to treat people with type 2 diabetes. Many large, well-done research studies of thousands of people have clearly shown that these drugs can improve glucose control, reduce the need for other glucose lowering drugs, and promote weight...
Learn more